首页> 外文期刊>Journal of Medical Sciences >Comparison of the Antibacterial Efficacies of Co-trimazine and Co-trimoxazole Against Listeria monocytogenes in Cyclosporin A Treated Mice
【24h】

Comparison of the Antibacterial Efficacies of Co-trimazine and Co-trimoxazole Against Listeria monocytogenes in Cyclosporin A Treated Mice

机译:复方新诺明和复方新诺明对环孢菌素A治疗的小鼠单核细胞增生李斯特菌的抗菌作用比较

获取原文
           

摘要

Listeria monocytogenes is a facultative, intracellular, gram positive bacterium that is responsible for sever infections, including prenatal infections, septicemia and meningoencephalitis in humans and a wide variety of animal species. In this study, efficacies of co-trimazine in an immunosuppressed mouse model of listeriosis was compared with co-trimoxazole. After treatment with co-trimazine (400 mg kg-1 of sulphadiazine and 80 mg kg-1 of trimethoprim) every 12 h for 3 days, Listeria monocytogenes could not recovered from the livers of the mice. In contrast, after treatment with co-trimoxazole (400 mg kg-1 sulphamethoxazole and 80 mg of trimethoprim) every 12 h for 3 days, a mean of 3 x 103 colony-forming unit (CFU) was recovered from the livers of mice. Results showed that antibacterial efficacy of co-trimazine was more than co-trimoxazole in experimental infections with Listeria monocytogenes .
机译:单核细胞增生李斯特菌是一种兼性的细胞内革兰氏阳性细菌,可引起严重感染,包括人类和多种动物的产前感染,败血病和脑膜脑炎。在这项研究中,将co-三嗪在免疫抑制的李斯特菌病小鼠模型中的功效与co-trimoxazole进行了比较。每12小时用三嗪(400 mg kg -1 的磺胺嘧啶和80 mg kg -1 的甲氧苄啶)处理3天后,单核细胞增生性李斯特菌无法从老鼠的肝脏。相反,每隔12小时用三甲恶唑(400 mg kg -1 磺胺甲恶唑和80 mg甲氧苄啶)治疗3天后,平均3 x 10 3 从小鼠肝脏中回收菌落形成单位(CFU)。结果显示,在单核细胞增生性李斯特菌的实验性感染中,复方新嗪的抗菌作用优于复方新唑。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号